FDA frees Abbott's Liberta RC DBS system for use
Abbott Laboratories received U.S. FDA clearance for its Liberta RC deep brain stimulation (DBS) system for use in movement disorders, less than two weeks after the agency gave its nod to Medtronic’s Percept RC DBS system. The news come on the heels of Abbott’s release of strong fourth quarter results on Wednesday.
Abbott Laboratories Bioworld Medtech 510k Clearance Parkinsons Disease Essential Tremor Abbott Laboratories Inc
Source: bioworld.com